Found 169 matching trials
Double Cord Versus Haploidentical (BMT CTN 1101) PHASE3 Hematopoietic cell transplants (HCT)are one treatment option for people wit...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders PHASE2 RATIONALE: Giving low doses of chemotherapy, such as fludarabine and cyclop...
Show More Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial
TT52CAR19 Therapy for B-cell Acute Lymphoblastic Leukaemia (B-ALL) PHASE1 PBLTT52CAR19 modified T cells are allogenic engineered human T cells (defin...
Show More Location
Great Ormond Street Hospital
Learn More & Join Trial
HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell Transplantation PHASE3 The MAC-HAPLO-MUD trial is a randomized prospective phase III trial compari...
Show More Location
Multiple Locations
Learn More & Join Trial
Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation EARLY_PHASE1 The primary objective is to assess the safety of the addition of venetoclax...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation EARLY_PHASE1 This research study is to determine if donor blood stem cells given after l...
Show More Location
Stanford University Medical Center
Learn More & Join Trial
Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT) NA This is a randomized phase II trial of standard-of-care reduced-intensity c...
Show More Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis PHASE2 The purpose of this study is to determine whether a regimen of high-dose im...
Show More Location
Children's Hospital of Pittsburgh of UPMC
Learn More & Join Trial
Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma PHASE2 Primary Objectives:
1. To determine the efficacy of administering multiple...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis PHASE1 This is a Phase I, single arm, open label, single center pilot study to ass...
Show More Location
Johns Hopkins University
Learn More & Join Trial